Brii Biosciences Limited (2137.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 914.23M |
| Enterprise Value | 314.52M |
| P/E Ratio | -3.64 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 34.25 |
| Price/Book Ratio | 0.29 |
| Enterprise/Revenue | 7.01 |
| Enterprise/EBITDA | -0.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -9.18 |
| Operating Margin | -14.78 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.07 |
Income Statement
| Revenue | 18.12M |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | -290.29M |
| Net Income | -216.86M |
| Diluted EPS | -0.3 |
Balance Sheet
| Total Cash | 1.77B |
| Total Cash/Share | 2.41 |
| Total Debt | 6.18M |
| Total Debt/Equity | 0 |
| Current Ratio | 52.24 |
| Book Value Per Share | 2.95 |
Price History
| 52-Week Change | -49.25 |
| 52-Week High | 2.34 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 0.99 |
| Moving Average 200 Days | 1.35 |
Statistics
| Average Volume | 704,228 |
| Shares Outstanding | 721.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
